Juno Therapeutics Reports Fourth Quarter and 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Juno Therapeutics (JUNO) Posts Q4 Loss of $1.61/Share
March 18, 2015 4:03 PM EDTJuno Therapeutics (NASDAQ: JUNO) reported Q4 EPS of ($1.61), $1.28 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Juno Therapeutics (JUNO) click here.
... More